California Court Dismisses Whistleblower Retaliation Claim Against Pfizer

2 min readSources: National Law Review

Northern District of California grants summary judgment to Pfizer in whistleblower retaliation case.

Why it matters: Employment lawyers should note how detailed performance records can outweigh whistleblower claims under California's Labor Code Section 1102.5, impacting retaliation litigation strategies.

  • Case: Han v. Pfizer, No. 23-cv-039080-AMO, Northern District of California.
  • Court recognized the employee’s whistleblowing as protected under California Labor Code Section 1102.5, which shields workers from retaliation.
  • Pfizer showed documented performance problems that began before whistleblowing complaints.
  • Judge ruled Pfizer had valid reasons for termination unrelated to whistleblowing, granting summary judgment to Pfizer.

In Han v. Pfizer (No. 23-cv-039080-AMO), the U.S. District Court for the Northern District of California dismissed a whistleblower retaliation claim after the plaintiff, a compliance analytics employee, alleged termination for reporting suspected legal violations.

California Labor Code Section 1102.5 protects employees who report suspected wrongdoing from retaliation. The court confirmed the employee's reporting was protected activity but focused on whether Pfizer’s termination decision was actually motivated by that conduct.

Pfizer provided extensive, contemporaneous documentation of performance problems spanning several years before the whistleblowing reports. The court explained this evidence showed that Pfizer would have fired the employee regardless of the protected activity.

The ruling means that even if an employee engages in whistleblowing, employers can defend against retaliation claims by proving independent grounds for termination. Clear and consistent performance records are critical in such defenses.

As attorneys Steven J. Pearlman, Hayden F. Bashinski, and Dixie M. Morrison commented, "Despite finding that evidence indicated the plaintiff had engaged in protected activity under Section 1102.5, the court granted summary judgment because the employer showed it would have terminated the plaintiff regardless."

This decision offers important guidance for legal professionals advising on employment disputes involving whistleblower claims under California law. Documentation and timing of employer actions remain decisive factors in litigation outcomes.

By the numbers:

  • No. 23-cv-039080-AMO — case number in Northern District of California
  • Several years — duration over which Pfizer documented performance issues prior to whistleblowing
  • Section 1102.5 — California statute protecting employees who report unlawful activity